Table 2. Data obtained at baseline in all patients and used in the minimization step in randomizing patients to the two trial arms.

Characteristic	Group 1 (N = 47) Control	Group 2 (N = 46) Metastasectomy
Gender
Male	28	31
Female	19	15
Age (years)
61+	33	32
60 or under	14	14
Lung metastases
1	16	18
2–4	26	24
5+	5	4
CEA (ng/ml)
<5	36	37
5-10	6	6
10+	5	3
Prior liver resection
Yes	13	14
No	34	32
Years since 1° CRC resection
<1	7	7
1-3	28	26
3+	12	13
CRC Stage
T stage
1	2	2
2	8	7
3+	37	37
N Stage
0	25	24
1+	22	22

Values represent the number of patients.

CEA, carcinoembryonic antigen; CRC, colorectal cancer.